The Impact Of Technological Innovation On The Performance Of Pharmaceutical Enterprises From The Perspective Of Life Cycle

Since the 21st century,the Chinese government has given priority to the development of the pharmaceutical industry as a strategic industry,continuously increased the investment in human,financial,material and technology,issued a large number of policies to encourage market players to participate in reform and innovation,and encouraged the industry to develop in the direction of intelligence,service and ecology.At present,China’s pharmaceutical industry performs well in terms of volume and growth rate,but subject to the characteristics of long R&D cycle and large investment of pharmaceutical products,there is still a large gap between the technological innovation level of pharmaceutical enterprises and the pharmaceutical manufacturing industry in developed countries,with low patent share and few innovative drugs.Enterprise technological innovation is a long-term and large-scale process,which involves the cooperation of various departments within the organization,the adaptation of external conditions and so on.Therefore,the technological innovation strategy should be adjusted according to different situations.However,the reasons for the selection of technological innovation strategy of pharmaceutical enterprises in the existing literature are mostly from the perspective of resource view,knowledge-based view and absorptive capacity,focusing on some factors,such as government policy,market concentration,technological environment,enterprise scale,enterprise capability,enterprise culture,etc.,to study the short-term utility of a certain kind of behavior,and technological innovation is a long-term process,Therefore,the success of the case is also difficult to copy.Life cycle theory is often used to interpret the strategic behavior of enterprises.The research perspective is more comprehensive and suitable for the evolution behavior of long-term technological innovation strategy.Therefore,this paper selects the life cycle perspective to analyze the impact of technological innovation behavior on innovation performance.In the research process,this paper combines the literature research method and case study method,and takes Hengrui pharmaceutical,an industry representative enterprise,as a case to study the whole process of enterprises from start-up to maturity.In each growth stage,it analyzes in detail the internal and external environmental conditions corresponding to technological innovation,and the arrangement of resources in the whole process of enterprises from R&D to production and then to sales under the guidance of various technological innovation modes,Then it comes to the evolution process of technological innovation strategy and its role in the short-term profitability and long-term development ability of enterprises.The results show that in the initial stage,pharmaceutical enterprises will choose imitation innovation strategy,obtain short-term technology purchase dividends and improve profitability by imitating popular drug production technology and accelerating knowledge transformation,and complete the accumulation of original capital and technology to slightly enhance their growth ability;During the growth period,pharmaceutical enterprises will choose cooperative innovation strategy,peel off irrelevant businesses and expand product categories to steadily enhance their profitability.At the same time,with the help of cooperation,disperse risks,learn the innovation knowledge of excellent enterprises,update talent technology,accelerate GMP and FDA certification,prepare for subsequent independent innovation,and significantly improve their growth ability;In the mature stage,pharmaceutical enterprises will choose independent innovation strategy,use "bring in,go out" to expand influence,accelerate the realization of R&D achievements,and strive to stabilize high profitability.At this time,the core business resources of the enterprise will focus on drug R&D,so as to accelerate patent application,develop new production lines,master the market voice,maintain the existing growth ability of the enterprise and find new technological breakthroughs,Find the next market area.